Celik M, Baba C, Irmak C, Ozakbas S, et al. Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. J Neurol 2024 Apr 5. doi: 10.1007/s00415-024-12333.
PMID: 38578494